Skip to main content
DNA Labs India

CRYBB3 Gene Cataract, Autosomal Recessive Congenital Nuclear Type 2 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CRYBB3 Gene Cataract, Autosomal Recessive Congenital Nuclear Type 2 NGS Genetic Test

Short Name: CRYBB3 Cataract NGS

Also known as: CRYBB3 Cataract Genetic Test, Autosomal Recessive Congenital Nuclear Cataract Type 2 NGS Panel, Inherited Cataract NGS Test

CRYBB3 Gene Cataract, Autosomal Recessive Congenital Nuclear Type 2 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS), Sanger confirmation for detected variants on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Samples are processed immediately. NGS sequencing and data analysis require laboratory time. Preliminary results may be available earlier, but final verified reports are issued within 3 to 4 weeks from sample receipt.. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS)All Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to detect mutations in the CRYBB3 gene responsible for autosomal recessive congenital nuclear type 2 cataract. It also screens other known cataract genes to provide a differential diagnosis and identify familial mutations. This NGS test supports clinical diagnosis, carrier detection, genotype-phenotype correlation, and genetic counselling for at-risk families.

Test Code
3779
CPT Code
N/A
ICD Code
Q12.0
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Samples are processed immediately. NGS sequencing and data analysis require laboratory time. Preliminary results may be available earlier, but final verified reports are issued within 3 to 4 weeks from sample receipt.
Fasting Required
No
Method
Next Generation Sequencing (NGS), Sanger confirmation for detected variants
Step 1

Sample Collection

No fasting or special preparation required. Patient should carry previous medical records and family history information. A genetic counselling session with pedigree charting is recommended and can be scheduled prior to sample collection.

Method: Peripheral venipuncture / Finger prick for FTA card

Step 2

Laboratory Analysis

Blood collection is performed using sterile technique. For FTA cards, a few drops of blood are spotted onto the card and allowed to air dry. The sample is then safely transported as per guidelines.

Step 3

Report Delivery

No post-collection precautions required. In case of discomfort at puncture site, apply gentle pressure. Resume normal activities immediately.

Timeline: Samples are processed immediately. NGS sequencing and data analysis require laboratory time. Preliminary results may be available earlier, but final verified reports are issued within 3 to 4 weeks from sample receipt.

Patient Instructions

1
Before the Test:No specific preparation needed. For home collection, you will receive an online counselling session. Discuss your complete family history and symptoms with the genetic counselor before the test. Your doctor may also request an ophthalmic examination report for correlative interpretation.
2
During the Test:The sample collection takes about 10 minutes. A trained phlebotomist will draw blood from your arm, or you may provide a few drops of blood on an FTA card if using home collection. The process is painless and safe.
3
After the Test:Once the sample reaches the laboratory, DNA extraction and NGS analysis will be initiated. The report will be sent to you within 3-4 weeks through email/WhatsApp. Discuss the results with your referring physician and a clinical geneticist to understand the medical and reproductive implications.

About This Test

Who Should Get This Test

The purpose of this test is to detect mutations in the CRYBB3 gene responsible for autosomal recessive congenital nuclear type 2 cataract. It also screens other known cataract genes to provide a differential diagnosis and identify familial mutations. This NGS test supports clinical diagnosis, carrier detection, genotype-phenotype correlation, and genetic counselling for at-risk families.

How to Prepare

  • Ensure the patient is correctly identified with full name and date of birth
  • For blood sample: use EDTA tube and mix gently by inversion to prevent clotting
  • For FTA card: apply blood drops only in the indicated circles
  • Label the sample with patient ID and date of collection
  • Store blood sample at 2-8°C if delay in dispatch; do not freeze whole blood
  • Avoid sample exposure to extreme heat or direct sunlight

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"Genetic testing is essential for accurate diagnosis and genetic counselling of families with congenital cataracts. NGS-based testing offers a comprehensive approach to identify the underlying cause, enabling early intervention and informed reproductive decisions."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood in EDTA Vacutainer
ContainerEDTA tube / FTA card / DNA vial
Collection MethodPeripheral venipuncture / Finger prick for FTA card

Sample Stability

Whole blood (EDTA) at room temperature (20-25°C)48 hours
Whole blood (EDTA) at 2-8°C7 days
Extracted DNA at -20°C6 months
FTA card at room temperature12 months
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Unlabelled or mislabeled sample
  • Sample received without consent or test requisition form
  • Container leaked during transport
  • Sample older than acceptance limit

Understanding Your Results

The genetic test report is interpreted by a clinical geneticist. A positive test identifies a pathogenic or likely pathogenic variant in the CRYBB3 gene, confirming the clinical diagnosis of autosomal recessive congenital nuclear type 2 cataract. A negative result reduces the likelihood of CRYBB3 involvement but does not rule out genetic causes due to variants in other genes or undetectable mutation types.
📊

Pathogenic variant detected

Confirms molecular diagnosis of CRYBB3-related autosomal recessive congenital nuclear type 2 cataract. Both alleles likely altered; carrier status requires further family analysis.

📊

Likely pathogenic variant detected

Highly suggestive causative variant; additional evidence from family segregation may be needed to confirm.

📊

No pathogenic variant detected

No known disease-causing variant identified in the CRYBB3 gene or analyzed panel genes. Other genetic or non-genetic causes may be present.

📊

Variant of uncertain significance (VUS)

A genetic variant was found but currently unknown correlation with disease. Further testing of affected family members may clarify its significance.

⚠️ When to Consult a Doctor:

Consult a clinical geneticist or genetic counsellor if you have a family history of congenital cataract, are a known carrier of a CRYBB3 mutation, or have a child with any form of cataract. Also consult an ophthalmologist if you or your child experience clouded or blurry vision, glare sensitivity, or difficulty with night vision. Early consultation can lead to timely surgical or optical management and appropriate reproductive counselling.

Limitations

  • NGS may not detect deep intronic variants, large gene deletions/duplications, or mitochondrial variants unless specifically analyzed
  • This test is not intended to determine disease severity or progression
  • Results should be interpreted in the context of clinical findings and family history
  • Genetic variants of uncertain significance (VUS) may be reported; additional family co-segregation analysis may be required

Risks & Considerations

  • No significant risks for blood sample collection
  • Minimal pain or bruising at venipuncture site
  • Rare chance of vasovagal episode during blood draw
  • Psychological impact after receiving genetic results (counselling provided)

Interfering Factors

  • Recent blood transfusion within 2 weeks may dilute nucleated cells and affect DNA extraction
  • Bone marrow transplant recipient: results may reflect donor DNA rather than patient's genetic constitution
  • Clotted blood sample due to improper storage or prolonged transit
  • Incorrect sample labelling or patient identification

Compare With Similar Tests

TestCRYBB3 Gene Cataract, Autosomal Recessive Congenital Nuclear Type 2 NGS Genetic TestSingle-gene CRYBB3 Sanger SequencingComprehensive Inherited Cataract NGS Panel
ComparisonCRYBB3 Gene Cataract, Autosomal Recessive Congenital Nuclear Type 2 NGS Genetic Test

Frequently Asked Questions

What is CRYBB3 Gene Cataract?
CRYBB3 gene cataract is a type of inherited cataract caused by mutations in the CRYBB3 gene, which provides instructions for making beta-B3-crystallin. It is inherited in an autosomal recessive pattern, meaning both parents must pass on a mutated gene. The condition typically affects the nucleus of the lens and may be present from birth (congenital).
What are common symptoms of CRYBB3-related cataract?
Common symptoms include clouding or opacity of the lens, blurred or double vision, reduced visual acuity, sensitivity to glare, difficulty seeing at night, and sometimes involuntary rapid eye movements (nystagmus) in infants.
How accurate is the NGS genetic test for cataract?
NGS testing is highly accurate for detecting variants in coding regions and splice sites of the analyzed genes. The sensitivity is above 98% for exonic single nucleotide variants and small insertions/deletions. However, very large structural variants or deep intronic changes may not be detected.
What is the cost of the CRYBB3 NGS genetic test at DNA Labs India?
The test costs INR 20,000, which includes home sample collection, NGS analysis, and a comprehensive report. No additional charges are applicable for standard pickup within most Indian cities.
How is the sample collected for this test?
A blood sample is drawn from a vein in your arm using a sterile needle. Alternatively, a few drops of blood can be collected on an FTA card via a simple finger prick. Both methods are safe and take less than 10 minutes.
Do I need to fast before the test?
No, fasting is not required for this genetic test. You can eat and drink normally before sample collection.
What is the turnaround time for results?
The report is typically delivered within 3 to 4 weeks from the date the sample is received at the laboratory. You will be notified by email or WhatsApp once the report is ready.
Will this test detect all types of congenital cataract?
This test focuses on CRYBB3 gene mutations and also includes a panel of common cataract-associated genes. It is not a whole-genome analysis, so it will not detect every possible genetic cause. However, it covers the most clinically relevant genes for congenital nuclear cataracts.
Can this test be done for children?
Yes, the test can be performed on children of any age. A small blood sample or FTA card blood spot is sufficient. For infants, the finger-prick method is often used for convenience.
What is the difference between Sanger sequencing and NGS?
Sanger sequencing is a traditional method that reads a single gene or a small region in one reaction, while NGS (next-generation sequencing) can analyze multiple genes simultaneously in a high-throughput manner. NGS is faster and more cost-effective when multiple genes need to be tested.
Is genetic counselling included in the test?
A pre-test and post-test genetic counselling session is recommended. While the test price includes the laboratory analysis and report, counselling is arranged separately. Our team can help you schedule a session with a certified genetic counsellor.
How will I receive my report?
Your report will be sent to your registered email address and also made available on our secure online portal. You can also receive it via WhatsApp if you prefer. A physical copy can be provided on request.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.